LABIANA HEALTH, S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.24 EUR | -.--% |
|
+12.00% | +79.20% |
| 2022 | Labiana Health, S.A. acquired 10.31% stake in Trichome Pharma. | CI |
| 2022 | Labiana Health, S.A. has completed an IPO in the amount of Ç5 million. | CI |
Evolution of the average Target Price on Labiana Health, S.A.
Price target over the last 5 years
History of analyst recommendation changes
80dcd2482f6aaa7036b2e88.ttJidFD7YmcW3p0M6JRqVdY2hZuT334tavPlYb_ivIY.-IcnTWOsTyhRnKlFqsEsP-9M18nR6lMAE5ywIsuV483jlisYY70sEX6WyA~339e257e9243e92b09b2aaed5cdcbeab
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.24
EUR
Average target price
2.4
EUR
Spread / Average Target
+7.14%
High Price Target
2.4
EUR
Spread / Highest target
+7.14%
Low Price Target
2.4
EUR
Spread / Lowest Target
+7.14%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- LAB Stock
- Consensus Labiana Health, S.A.
